Other
Drug Facts
The following Structured Product Label (SPL) was submitted to the FDA by Akorn for the product Sodium Chloride (NDC 17478-622). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding other, active ingredient, purpose, use, warnings, stop use and ask a doctor if, keep out of reach of children., directions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Drug Facts
Sodium Chloride 5%
Hypertonicity agent
for temporary relief of corneal edema.
you experience eye pain, changes in vision, continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours.
If swallowed, get medical help or contact a Poison Control Center right away.
Apply small amount (one-fourth inch) to the inside of affected eye(s) every 3 to 4 hours, or as directed by a doctor.
Mineral Oil, Modified Lanolin, Water for Injection and White Petrolatum.
Principal Display Panel Text for Container Label:
NDC 17478-622-35
Sodium Chloride Ophthalmic
Ointment USP, 5%
Hypertonicity Eye Ointment Sterile
FOR OPHTHALMIC USE ONLY. Net Wt. 3.5 g (1/8 oz.)
Principal Display Panel Text for Carton Label:
NDC 17478-622-35
3.5 g
Sodium
Chloride
Ophthalmic
Ointment
USP, 5%
Hypertonicity
Eye Ointment
Comparable to MURO 128®
Sterile
Net Wt. 3.5 g (1/8 oz.)
* Please review the disclaimer below.